[HTML][HTML] Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection
Background Treatment with peginterferon alfa-2a alone produces significantly higher sustained
virologic responses than treatment with interferon alfa-2a alone in patients with chronic …
virologic responses than treatment with interferon alfa-2a alone in patients with chronic …
[HTML][HTML] Boceprevir for untreated chronic HCV genotype 1 infection
…, MS Sulkowski, IM Jacobson, KR Reddy… - … England Journal of …, 2011 - Mass Medical Soc
Background Peginterferon–ribavirin therapy is the current standard of care for chronic infection
with hepatitis C virus (HCV). The rate of sustained virologic response has been below 50…
with hepatitis C virus (HCV). The rate of sustained virologic response has been below 50…
[HTML][HTML] Telaprevir for previously untreated chronic hepatitis C virus infection
…, G Dusheiko, AM Di Bisceglie, KR Reddy… - … England Journal of …, 2011 - Mass Medical Soc
Background In phase 2 trials, telaprevir, a hepatitis C virus (HCV) genotype 1 protease
inhibitor, in combination with peginterferon–ribavirin, as compared with peginterferon–ribavirin …
inhibitor, in combination with peginterferon–ribavirin, as compared with peginterferon–ribavirin …
Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection
…, NT Pyrsopoulos, ZZ Feng, KR Reddy… - The American journal of …, 2002 - Elsevier
OBJECTIVES: Needle liver biopsy has been shown to have a high rate of sampling error in
patients with diffuse parenchymal liver diseases. In these cases, the sample of liver tissue …
patients with diffuse parenchymal liver diseases. In these cases, the sample of liver tissue …
Managing agricultural phosphorus for protection of surface waters: Issues and options
…, JT Sims, TC Daniel, KR Reddy - Journal of …, 1994 - Wiley Online Library
The accelerated eutrophication of most freshwaters is limited by P inputs. Nonpoint sources
of P in agricultural runoff now contribute a greater portion of freshwater inputs, due to easier …
of P in agricultural runoff now contribute a greater portion of freshwater inputs, due to easier …
[HTML][HTML] Sofosbuvir for previously untreated chronic hepatitis C infection
…, MN Davis, Z Kayali, KR Reddy… - … England Journal of …, 2013 - Mass Medical Soc
Background In phase 2 trials, the nucleotide polymerase inhibitor sofosbuvir was effective in
previously untreated patients with chronic hepatitis C virus (HCV) genotype 1, 2, or 3 …
previously untreated patients with chronic hepatitis C virus (HCV) genotype 1, 2, or 3 …
[BOOK][B] Biogeochemistry of wetlands: science and applications
… and KR Reddy . 2004. Response of biogeochemical indicators to a drawdown and subsequent
… D’Angelo, EM and KR Reddy . 1999. Regulators of heterotrophic microbial potentials in …
… D’Angelo, EM and KR Reddy . 1999. Regulators of heterotrophic microbial potentials in …
[HTML][HTML] Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection
Background Effective treatment for hepatitis C virus (HCV) genotype 1 infection in patients
who have not had a sustained virologic response to prior interferon-based therapy represents …
who have not had a sustained virologic response to prior interferon-based therapy represents …
[HTML][HTML] Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection
…, M Rodriguez-Torres, KR Reddy… - … England Journal of …, 2014 - Mass Medical Soc
Background All-oral combination therapy is desirable for patients with chronic hepatitis C
virus (HCV) infection. We evaluated daclatasvir (an HCV NS5A replication complex inhibitor) …
virus (HCV) infection. We evaluated daclatasvir (an HCV NS5A replication complex inhibitor) …
[HTML][HTML] Ledipasvir and sofosbuvir for 8 or 12 weeks for chronic HCV without cirrhosis
Background High rates of sustained virologic response were observed among patients with
hepatitis C virus (HCV) infection who received 12 weeks of treatment with the nucleotide …
hepatitis C virus (HCV) infection who received 12 weeks of treatment with the nucleotide …